Internal Server Error

Samsung BioLogics - About the company

Samsung BioLogics is a public company based in Incheon (South Korea), founded in 2011. It operates as a CDMO focused on biologics development & manufacturing services. The company has 369 active competitors, including 41 funded and 53 that have exited. Its top competitors include companies like Novartis, Catalent and Surrozen.

Company Details

Social
Facebook
Part Of
Key Metrics
Founded Year
2011
Location
Incheon, South Korea
Stage
Public
Investors
Ranked
Employee Count
1,998 as on Oct 05, 2025
Investment & Acquisitions
Similar Companies
Exit Details
Public

Samsung BioLogics's IPO details

Samsung BioLogics got listed on Nov 10, 2016.
Click here to take a look at Samsung BioLogics's IPO in detail
Sign up to download Samsung BioLogics' company profile

Samsung BioLogics's funding and investors

Samsung BioLogics is a funded company. Samsung BioLogics has 2 institutional investors.

Samsung BioLogics' founders and board of directors

Founder? Claim Profile

Samsung BioLogics' employee count trend

Samsung BioLogics has 1,998 employees as of Oct 25. Here is Samsung BioLogics's employee count trend over the years:
Employee count trend for Samsung BioLogics
lockUncover Samsung BioLogics' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Samsung BioLogics's Competitors and alternates

Top competitors of Samsung BioLogics include Novartis, Catalent and Surrozen. Here is the list of Top 10 competitors of Samsung BioLogics, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Novartis
Novartis
1996, Basel (Switzerland), Public
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
70/100
2nd
Logo for Catalent
Catalent
2007, Somerset (United States), Acquired
Provider of development, manufacturing, and packaging solutions for medicines and supplements
-
68/100
3rd
Logo for Surrozen
Surrozen
2016, San Francisco (United States), Public
Pioneering targeted regenerative antibodies to repair tissue and restore organ function
$133M
66/100
4th
Logo for Biotage
Biotage
1989, Uppsala (Sweden), Acquired
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
-
62/100
5th
Logo for BioFactura
BioFactura
2004, Frederick (United States), Series B
Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs
$7.8M
56/100
6th
Logo for Full-Life Technologies
Full-Life Technologies
2021, Shanghai (China), Series C
Provider of discovery, development, production, and logistics services for of nuclear medicines
$200M
56/100
7th
Logo for Tirupati Medicare
Tirupati Medicare
1980, Paonta Sahib (India), Series B
Contract manufacturer of pharmaceutical products
$51.5M
55/100
8th
Logo for Acclinate
Acclinate
2020, Birmingham (United States), Series A
Provider of clinical trial services to biopharma sector
$12M
54/100
9th
Logo for AmplifyBio
AmplifyBio
2021, Hilliard (United States), Deadpooled
Provider of contract research, development, and manufacturing services for biologic drugs
$230M
53/100
10th
Logo for Curia
Curia
1991, Albany (United States), Acquired
Provider of drug research & development, testing, and consulting services
-
52/100
17th
Logo for Samsung BioLogics
Samsung BioLogics
2011, Incheon (South Korea), Public
CDMO focused on biologics development & manufacturing services
-
46/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Samsung BioLogics's competitors? Click here to see the top ones

Samsung BioLogics's Investments and acquisitions

Samsung BioLogics has made 3 investments in companies including Arbor Biotechnologies and C₂N Diagnostics. Samsung BioLogics has also acquired 3 companies including Human Genome Sciences and Samsung Bioepis.
Here is the list of investments & acquisitions:
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Dec 21, 2025
Acquisition
1992
Rockville (United States)
Oct 30, 2025
Investments
2016
Cambridge (United States)
Mar 13, 2025
Investments
2007
St. Louis (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all investments by Samsung BioLogics

News related to Samsung BioLogics

lockFilter this list
Media has covered Samsung BioLogics for a total of 55 events in the last 1 year, 31 of them have been about company updates and 3 about partnerships.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Samsung BioLogics

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford